{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:30:55Z","timestamp":1786113055989,"version":"build-2736575974"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,9]]},"abstract":"<jats:p>\n                    This study aimed to investigate the bidirectional causal relationship between lipidomes and ulcerative colitis (UC) using a 2-step, 2-sample Mendelian randomization (MR) analysis. We also examined the mediating role of inflammatory proteins as intermediaries. We screened relevant summary statistics from European populations and conducted a 2-sample, bidirectional MR analysis on 179 lipids and UC using the inverse variance-weighted method. Causal effects were further validated through Bayesian-weighted MR. A 2-step MR analysis was performed to assess the mediating role of inflammatory proteins. Sensitivity, heterogeneity, and horizontal pleiotropy analyses were conducted to confirm the robustness of the causal relationships. The MR analysis demonstrated a significant positive association between PC (17:0_18:2) and UC (odds ratio [OR]\u2005=\u20051.159, 95% confidence interval [CI]\u2005=\u20051.062\u20131.266,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u20054.01e-5). TNFSF12 was also positively associated with UC (OR\u2005=\u20051.096, 95% CI\u2005=\u20051.011\u20131.189,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.027). However, PC (17:0_18:2) and TNFSF12 were negatively correlated (OR\u2005=\u20050.943, 95% CI\u2005=\u20050.898\u20130.990,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.018), with a mediation proportion of 3.67%. Our findings identified causal relationships between 9 lipidomes and 2 inflammatory proteins with UC. TNFSF12 showed a masking effect on UC for PC (17:0_18:2).\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000047016","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:00:44Z","timestamp":1767988844000},"page":"e47016","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Inflammatory proteins mediating the effects of lipidomes on ulcerative colitis: A two-step Mendelian randomization study"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5460-9182","authenticated-orcid":false,"given":"Jie","family":"Fu","sequence":"first","affiliation":[{"name":"College of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"},{"name":"College of Acupuncture and Orthopedics, Hubei University of Chinese Medicine, Wuhan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260805","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis.","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet"},{"key":"R2-20260805","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/ecco-jcc\/jjae088","article-title":"Early and sustained symptom control with mirikizumab in patients with ulcerative colitis in the phase 3 LUCENT program.","volume":"18","author":"Danese","year":"2024","journal-title":"J Crohns Colitis"},{"key":"R3-20260805","doi-asserted-by":"crossref","first-page":"9589","DOI":"10.3390\/ijms25179589","article-title":"The role of host genetics and intestinal microbiota and metabolome as a new insight into IBD pathogenesis.","volume":"25","author":"Zakerska-Banaszak","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R4-20260805","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/ueg2.12671","article-title":"Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: a systematic review and future perspective.","volume":"12","author":"Parigi","year":"2024","journal-title":"United European Gastroenterol J"},{"key":"R5-20260805","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/ueg2.12677","article-title":"Epithelial neutrophil localization and tight junction Claudin-2 expression are innovative outcome predictors in inflammatory bowel disease.","volume":"12","author":"Zammarchi","year":"2024","journal-title":"United European Gastroenterol J"},{"key":"R6-20260805","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD.","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"R7-20260805","doi-asserted-by":"crossref","first-page":"17562848241239580","DOI":"10.1177\/17562848241239580","article-title":"Systematic review of metabolomic alterations in ulcerative colitis: unveiling key metabolic signatures and pathways.","volume":"17","author":"Liu","year":"2024","journal-title":"Therap Adv Gastroenterol"},{"key":"R8-20260805","doi-asserted-by":"crossref","first-page":"1198988","DOI":"10.3389\/fmed.2023.1198988","article-title":"Association of serum lipids with inflammatory bowel disease: a systematic review and meta-analysis.","volume":"10","author":"Chen","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"R9-20260805","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3390\/pharmaceutics16091185","article-title":"Advancements in inflammatory bowel disease management: from traditional treatments to monoclonal antibodies and future drug delivery systems.","volume":"16","author":"Di Rienzo","year":"2024","journal-title":"Pharmaceutics"},{"key":"R10-20260805","doi-asserted-by":"crossref","first-page":"101182","DOI":"10.1016\/j.plipres.2022.101182","article-title":"Lipid-protein interactions regulating the canonical and the non-canonical NLRP3 inflammasome.","volume":"87","author":"Pizzuto","year":"2022","journal-title":"Prog Lipid Res"},{"key":"R11-20260805","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.7150\/ijbs.81017","article-title":"A lipid perspective on regulated pyroptosis.","volume":"19","author":"Qiu","year":"2023","journal-title":"Int J Biol Sci"},{"key":"R12-20260805","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1681\/ASN.2016010098","article-title":"Mendelian randomization as an approach to assess causality using observational data.","volume":"27","author":"Sekula","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R13-20260805","doi-asserted-by":"crossref","first-page":"n2233","DOI":"10.1136\/bmj.n2233","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration.","volume":"375","author":"Skrivankova","year":"2021","journal-title":"BMJ"},{"key":"R14-20260805","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1038\/s41467-023-42532-8","article-title":"Genome-wide association analysis of plasma lipidome identifies 495 genetic associations.","volume":"14","author":"Ottensmann","year":"2023","journal-title":"Nat Commun"},{"key":"R15-20260805","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","article-title":"Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.","volume":"24","author":"Zhao","year":"2023","journal-title":"Nat Immunol"},{"key":"R16-20260805","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population.","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"R17-20260805","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1158\/0008-5472.CAN-20-0985","article-title":"LDtrait: an online tool for identifying published phenotype associations in linkage disequilibrium.","volume":"80","author":"Lin","year":"2020","journal-title":"Cancer Res"},{"key":"R18-20260805","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1093\/eurheartj\/ehad736","article-title":"Mendelian randomization for cardiovascular diseases: principles and applications.","volume":"44","author":"Larsson","year":"2023","journal-title":"Eur Heart J"},{"key":"R19-20260805","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/bioinformatics\/btz749","article-title":"Bayesian weighted Mendelian randomization for causal inference based on summary statistics.","volume":"36","author":"Zhao","year":"2020","journal-title":"Bioinformatics"},{"key":"R20-20260805","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/apt.15562","article-title":"Crohn\u2019s disease and ulcerative colitis are associated with different lipid profile disorders: a nationwide population-based study.","volume":"51","author":"Soh","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"R21-20260805","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/ajg.2011.44","article-title":"Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature.","volume":"106","author":"Hou","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"R22-20260805","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.jmb.2019.09.016","article-title":"Recent insights into mechanisms of \u03b2-cell lipo- and glucolipotoxicity in type 2 diabetes.","volume":"432","author":"Lytrivi","year":"2020","journal-title":"J Mol Biol"},{"key":"R23-20260805","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/intimm\/dxac025","article-title":"Fatty acid metabolism in T-cell function and differentiation.","volume":"34","author":"Endo","year":"2022","journal-title":"Int Immunol"},{"key":"R24-20260805","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/intimm\/dxae031","article-title":"Lipid metabolism: a central modulator of ROR\u03b3t-mediated Th17 cell differentiation.","volume":"36","author":"Kanno","year":"2024","journal-title":"Int Immunol"},{"key":"R25-20260805","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.3390\/ijms20184522","article-title":"Oxysterols in autoimmunity.","volume":"20","author":"Duc","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R26-20260805","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4161\/gmic.2.3.16104","article-title":"Intestinal steroid profiles and microbiota composition in colitic mice.","volume":"2","author":"Wohlgemuth","year":"2011","journal-title":"Gut Microbes"},{"key":"R27-20260805","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/febs.17269","article-title":"A high cholesterol diet aggravates experimental colitis through SREBP2-modulated endocytosis and degradation of occludin and Zo-1 proteins.","volume":"292","author":"Yang","year":"2024","journal-title":"FEBS J"},{"key":"R28-20260805","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00018-014-1778-x","article-title":"Sphingolipid metabolism and its role in the skeletal tissues.","volume":"72","author":"Khavandgar","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"R29-20260805","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jare.2024.03.026","article-title":"Sedanolide alleviates DSS-induced colitis by modulating the intestinal FXR-SMPD3 pathway in mice.","volume":"69","author":"Li","year":"2024","journal-title":"J Adv Res"},{"key":"R30-20260805","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrm.2017.138","article-title":"Understanding the diversity of membrane lipid composition.","volume":"19","author":"Harayama","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R31-20260805","doi-asserted-by":"crossref","first-page":"26807","DOI":"10.1021\/acsnano.4c07658","article-title":"Gastrointestinal self-adaptive and nutrient self-sufficient akkermansia muciniphila-gelatin porous microgels for synergistic therapy of ulcerative colitis.","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS Nano"},{"key":"R32-20260805","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1159\/000514355","article-title":"Delayed-release phosphatidylcholine is effective for treatment of ulcerative colitis: a meta-analysis.","volume":"39","author":"Stremmel","year":"2021","journal-title":"Dig Dis"},{"key":"R33-20260805","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.2174\/1381612829666221124112803","article-title":"Exploring the phosphatidylcholine in inflammatory bowel disease: potential mechanisms and therapeutic interventions.","volume":"28","author":"Ai","year":"2022","journal-title":"Curr Pharm Des"},{"key":"R34-20260805","doi-asserted-by":"crossref","first-page":"158854","DOI":"10.1016\/j.bbalip.2020.158854","article-title":"Bioactive lipids in inflammatory bowel diseases - From pathophysiological alterations to therapeutic opportunities.","volume":"1866","author":"Alhouayek","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"R35-20260805","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fimmu.2018.00038","article-title":"Bioactive lipids and chronic inflammation: managing the fire within.","volume":"9","author":"Chiurchi\u00f9","year":"2018","journal-title":"Front Immunol"},{"key":"R36-20260805","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1053\/j.gastro.2016.10.020","article-title":"Understanding and preventing the global increase of inflammatory bowel disease.","volume":"152","author":"Kaplan","year":"2017","journal-title":"Gastroenterology"},{"key":"R37-20260805","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMra2002697","article-title":"Pathophysiology of inflammatory bowel diseases.","volume":"383","author":"Chang","year":"2020","journal-title":"N Engl J Med"},{"key":"R38-20260805","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1053\/j.gastro.2024.07.046","article-title":"Comparative efficacy of advanced therapies for management of moderate-to-severe ulcerative colitis: 2024 American Gastroenterological Association evidence synthesis.","volume":"167","author":"Ananthakrishnan","year":"2024","journal-title":"Gastroenterology"},{"key":"R39-20260805","doi-asserted-by":"crossref","first-page":"117390","DOI":"10.1016\/j.biopha.2024.117390","article-title":"Exploring the influence of non-coding RNAs on NF-\u03baB signaling pathway regulation in ulcerative colitis.","volume":"179","author":"Pourmehran","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"R40-20260805","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/bph.12337","article-title":"The TWEAK-Fn14 system as a potential drug target.","volume":"170","author":"Wajant","year":"2013","journal-title":"Br J Pharmacol"},{"key":"R41-20260805","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3390\/molecules28020494","article-title":"Short-chain fatty acids attenuate 5-fluorouracil-induced THP-1 cell inflammation through inhibiting NF-\u03baB\/NLRP3 signaling via glycerolphospholipid and sphingolipid metabolism.","volume":"28","author":"Zhang","year":"2023","journal-title":"Molecules"},{"key":"R42-20260805","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3390\/membranes13020141","article-title":"Phosphatidylcholine liposomes reprogram macrophages toward an inflammatory phenotype.","volume":"13","author":"Cauvi","year":"2023","journal-title":"Membranes (Basel)"},{"key":"R43-20260805","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1016\/j.molcel.2021.08.027","article-title":"Lipid metabolism in sickness and in health: emerging regulators of lipotoxicity.","volume":"81","author":"Yoon","year":"2021","journal-title":"Mol Cell"},{"key":"R44-20260805","doi-asserted-by":"crossref","first-page":"1434600","DOI":"10.3389\/fcvm.2024.1434600","article-title":"The role of inflammatory proteins in regulating the impact of lipid specifications on deep venous thrombosis: a two sample and mediated Mendelian randomization study.","volume":"11","author":"Dong","year":"2024","journal-title":"Front Cardiovasc Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T17:00:24Z","timestamp":1785949224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047016","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"2025-07-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}